🇮🇳IN
Sign In
RO

ROSSARI

NSE

Rossari Biotech Ltd

₹414.70

-12.60(-2.95%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

ROSSARI financial summary

For Mar 2026, Rossari Biotech Ltd reported revenue of ₹1,752 crore, which grew 22.3% from the previous year. Net profit was ₹143 crore, which grew 24.3% year on year, on an operating margin of 12%. Earnings per share came in at ₹25.79. Annual results are available for 12 financial years, from Mar 2011 to Mar 2026.

Revenue₹1,752 crore
Net profit₹143 crore
Operating margin12%
EPS₹25.79

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer